ArticleScientific reports2023
Highly sensitive asymmetric and symmetric cancer sensors with ultra-high-quality factor and resolution power.
Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 8 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the paper, we proposed two new highly sensitive and compact biosensors with ultra-high-quality factors based on the 1-D binary photonic crystal (silicon/air thin layer) with a defect layer. The proposed asymmetric and symmetric biosensors have just a few periods (two to five) on both sides of the defect layer and the normal cell group (INOK) and cancer cells group (YD-10B) are considered for the studies. The effects of different parameters including silicon layer thickness, air layer thickness, defect layer thickness, substrate position, number of periods, and light incident angle are considered in the biosensor operation and the biosensors are optimized based on the sensitivity. The results demonstrate that the sensitivity and defect mode wavelength of the sensors are independent of the substrate position. However, the quality factor and FOM of the sensors significantly depend on the substrate position and they are improved significantly in the symmetric sensor (~ 37% improvement in optimum condition). Also, the high sensitivities of the sensors are maintained over a wide range of silicon and air thicknesses, which is a valuable achievement in the manufacturing process. Furthermore, the sensitivity of the optimized biosensors with a defect layer thickness of 10 microns and only two periods reaches S ~ 2811 nm/RIU which is an excellent sensitivity for an optical biosensor.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.